Abrilada

Pfizer Patient Assistance Program Patient Guide: How to Get Abrilada (Adalimumab-afzb) at Low or No Cost

About Abrilada

Abrilada (adalimumab-afzb) is a biosimilar medication used to treat various inflammatory conditions. As a biosimilar, it works similarly to the original biologic drug and may offer a more affordable treatment option for eligible patients. This guide explains how you can access Abrilada through the Pfizer Patient Assistance Program at reduced or no cost if you qualify.

Who Qualifies for This Program?

The Pfizer Patient Assistance Program is designed to help patients who cannot afford their medications. To be eligible, you must meet the following basic requirements:

• Be 18 years of age or older
• Reside in the United States or a U.S. territory
• Have a valid prescription for Abrilada written by a licensed U.S. healthcare provider
• Be treated in an outpatient setting
• Have an FDA-approved diagnosis for which Abrilada is prescribed
• Be unable to afford your prescription costs

Insurance Requirements

Your insurance status determines your eligibility:

You may qualify if you are:

• Uninsured (have no health insurance coverage)
• Underinsured (have insurance but cannot afford your out-of-pocket costs)
• Insured through a government program (such as Medicare or Medicaid) and unable to afford your costs

You are NOT eligible if you:

• Have commercial insurance through your employer or a Federal Employer Plan
• Have adequate coverage that makes the medication affordable

If you have commercial insurance, you should first explore co-pay assistance programs or speak with your healthcare provider about other options before applying.

Income Eligibility

While specific income thresholds vary by program and medication, the Pfizer Patient Assistance Program generally serves patients with limited household income. Income limits are typically set at 500% of the federal poverty level, though exact thresholds may vary. You will need to provide proof of your household income during the application process.

Note: These are approximate 2026 estimates based on federal poverty guidelines. Actual limits may vary. Contact Pfizer for current thresholds.

Required Documents

Before you apply, gather the following documents:

• Completed enrollment form (provided by Pfizer)
• Proof of income (choose one):
  • Most recent federal tax return (Form 1040)
  • W-2 form(s)
  • Recent paycheck stub(s)
  • Social Security, pension, or railroad retirement statements
• Proof of residency (such as a utility bill or lease agreement)
• Valid prescription for Abrilada from your healthcare provider
• Insurance information (if applicable, including insurance cards)
• Medicare information (if you have Medicare Part D or Medicare Advantage)

How to Apply

Step 1: Gather Your Information

Collect all required documents listed above. Make copies of any documents you'll be submitting.

Step 2: Contact Pfizer

Call the Pfizer Patient Assistance Program at (844) 989-7284 to request an enrollment form or to begin your application. You can also visit www.PfizerRxPathways.com to access the Program Finder and start your application online through Pfizer PAP Connect if available for your medication.

Step 3: Complete the Enrollment Form

Fill out all required sections of the enrollment form completely and accurately. Sign and date the form where indicated. If you cannot complete the form yourself, a caregiver, family member, or healthcare provider can assist you.

Step 4: Submit Your Application

You have two options:

• Online: Upload your completed form and documents through Pfizer PAP Connect at www.PfizerRxPathways.com
• By Mail or Fax: Mail or fax your completed enrollment form and supporting documents to:
  • Pfizer Patient Assistance Program
  • P.O. Box 66585
  • St. Louis, MO 63166-6585
  • Fax: 1-877-548-1734

Step 5: Wait for Approval

Pfizer will review your application and notify you of your enrollment status within 2 to 3 weeks.

Timeline and Medication Delivery

Application Review: You will receive notification of your approval or denial status within 2 to 3 weeks of submitting your complete application.

If Approved: Once approved, you will receive a letter with your enrollment term and instructions on how to receive your medication. Your Abrilada will be shipped directly to you or your healthcare provider.

Ongoing Support: Your enrollment is not permanent. You will need to reauthorize your assistance periodically to continue receiving medication through the program.

What If Your Application Is Denied?

If your application is denied, you have several options:

• Request clarification: Contact Pfizer to understand why you were denied and whether you can provide additional information
• Reapply: If your circumstances change (such as income reduction or insurance status change), you can reapply
• Explore alternatives: Ask your healthcare provider about:
  • Other patient assistance programs
  • Generic or biosimilar alternatives
  • State pharmaceutical assistance programs
  • Nonprofit organizations that help with medication costs
  • Humira (adalimumab), the original biologic medication, which may have its own assistance programs

Reauthorization

Your assistance through the Pfizer Patient Assistance Program is not permanent. You will need to reauthorize your enrollment periodically. Pfizer will notify you when reauthorization is required. Be prepared to provide updated income documentation and other required information to continue receiving your medication at no or reduced cost.

Important Disclaimer

This guide provides general information about the Pfizer Patient Assistance Program for Abrilada. Program details, eligibility requirements, and income thresholds are subject to change at any time. For the most current and accurate information, contact Pfizer directly at (844) 989-7284 or visit www.PfizerRxPathways.com. Always consult with your healthcare provider about your treatment options and eligibility for assistance programs. This information is not a guarantee of enrollment or assistance.